pentylenetetrazole has been researched along with ro 19-8022 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haugvicová, R; Kubová, H; Mares, P; Mikulecká, A | 1 |
| Kubová, H; Mareš, P; Mikulecká, A | 1 |
| Kubová, H; Mareš, P | 1 |
3 other study(ies) available for pentylenetetrazole and ro 19-8022
| Article | Year |
|---|---|
The benzodiazepine receptor partial agonist Ro 19-8022 suppresses generalized seizures without impairing motor functions in developing rats.
Topics: Aging; Animals; Anticonvulsants; Convulsants; Dose-Response Relationship, Drug; GABA-A Receptor Antagonists; Male; Midazolam; Motor Skills; Pentylenetetrazole; Pyrrolidines; Quinolizines; Rats; Rats, Wistar; Seizures; Time Factors | 1999 |
Rebound increase in seizure susceptibility but not isolation-induced calls after single administration of clonazepam and Ro 19-8022 in infant rats.
Topics: Analysis of Variance; Animals; Animals, Newborn; Clonazepam; Disease Susceptibility; GABA Modulators; Male; Motor Activity; Pentylenetetrazole; Pyrrolidines; Quinolizines; Rats; Rats, Wistar; Receptors, GABA-A; Seizures; Vocalization, Animal | 2011 |
Partial agonist of benzodiazepine receptors Ro 19-8022 elicits withdrawal symptoms after short-term administration in immature rats.
Topics: Age Factors; Animals; Anticonvulsants; Brain; Carrier Proteins; Disease Models, Animal; Drug Administration Schedule; Drug Partial Agonism; Male; Pentylenetetrazole; Pyrrolidines; Quinolizines; Rats; Rats, Wistar; Receptors, GABA-A; Seizures; Substance Withdrawal Syndrome; Time Factors | 2012 |